Efficacy of Carvedilol Treatment on Cardiac Function and Cardiac Sympathetic Nerve Activity in Patients with Dilated Cardiomyopathy: Comparison with Metoprolol Therapy

Overview

Journal J Nucl Med

Specialty Nuclear Medicine

Date 2003 Oct 8

PMID 14530474

Citations 18

Authors

Takuji Toyama

Hiroshi Hoshizaki

Ryotaro Seki

Naoki Isobe

Hitoshi Adachi

Shigeto Naito

Shigeru Oshima

Koichi Taniguchi

Affiliations

Soon will be listed here.

Abstract

Unlabelled: Carvedilol and metoprolol have been reported to be effective in the treatment of patients with chronic heart failure. However, to our knowledge, there have been no studies comparing the effects of the 2 drugs on cardiac function, including cardiac sympathetic nerve activity.

Methods: We compared 15 patients with dilated cardiomyopathy (DCM) who were receiving carvedilol (group A) with 15 patients with DCM who were receiving metoprolol (group B). Before and after 1 y of treatment, cardiac (123)I-metaiodobenzylguanidine ((123)I-MIBG) uptake was assessed using the total defect score (TDS) and the heart-to-mediastinum (H/M) activity ratio from the delayed images. The New York Heart Association (NYHA) class and echocardiographic left ventricular ejection fraction (LVEF) also were assessed.

Results: In both groups, the TDS decreased (in group A, from 25 +/- 14 to 16 +/- 14, P < 0.01; in group B, from 27 +/- 9 to 19 +/- 10, P < 0.01), the H/M increased (in group A, from 1.67 +/- 0.31 to 2.01 +/- 0.36, P < 0.01; in group B, from 1.68 +/- 0.21 to 1.93 +/- 0.32, P < 0.01), the LVEF increased (in group A, from 31% +/- 10% to 48% +/- 10%, P < 0.01; in group B, from 28% +/- 9% to 47% +/- 15%, P < 0.01), and the NYHA functional class improved (in group A, from 2.9 +/- 0.3 to 1.7 +/- 0.5, P < 0.01; in group B, from 2.8 +/- 0.6 to 1.7 +/- 0.6, P < 0.01). The change in LVEF was mildly correlated with the change in the TDS in group A (r = 0.41) as well as in group B (r = 0.53). In the patients with a favorable response in the TDS or H/M, the NYHA class improved more than in the patients without a favorable response (P < 0.05).

Conclusion: Carvedilol treatment can improve cardiac function, symptoms, and cardiac sympathetic nerve activity in patients with DCM to a similar extent as metoprolol treatment. The improvement of cardiac function and symptoms is related to the improvement of cardiac sympathetic nerve activity.

Citing Articles

Autonomic nervous system and cardiac neuro-signaling pathway modulation in cardiovascular disorders and Alzheimer's disease.

Elia A, Fossati S Front Physiol. 2023; 14:1060666.

PMID: 36798942 PMC: 9926972. DOI: 10.3389/fphys.2023.1060666.

Assessment of therapeutic effects of statin on cardiac sympathetic nerve activity after reperfusion therapy in patients with first ST-segment elevation myocardial infarction and normal low-density lipoprotein cholesterol.

Takahashi S, Kasama S, Toyama T, Suzuki S, Ito Y, Nakata T J Nucl Cardiol. 2019; 28(4):1449-1457.

PMID: 31440976 DOI: 10.1007/s12350-019-01857-y.

Roles of cardiac sympathetic neuroimaging in autonomic medicine.

Goldstein D, Cheshire Jr W Clin Auton Res. 2018; 28(4):397-410.

PMID: 30062642 PMC: 8917443. DOI: 10.1007/s10286-018-0547-6.

Comparative effects of long-acting and short-acting loop diuretics on cardiac sympathetic nerve activity in patients with chronic heart failure.

Matsuo Y, Kasama S, Toyama T, Funada R, Takama N, Koitabashi N Open Heart. 2016; 3(1):e000276.

PMID: 26870386 PMC: 4746525. DOI: 10.1136/openhrt-2015-000276.

Effects of adding intravenous nicorandil to standard therapy on cardiac sympathetic nerve activity and myocyte dysfunction in patients with acute decompensated heart failure.

Kasama S, Toyama T, Funada R, Takama N, Koitabashi N, Ichikawa S Eur J Nucl Med Mol Imaging. 2015; 42(5):761-70.

PMID: 25634117 DOI: 10.1007/s00259-015-2990-0.